M&G Investment Management’s ResMed RMD Stock Holding History

M&G Investment Management’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-40,766	Closed	-$6.03M	–	367
2023 Q3	$6.03M	Buy	+40,766	New	+$7.37M	0.03%	272
2022 Q2	–	Sell	-908	Closed	-$221	–	471
2022 Q1	$221	Sell	908 -4,495	-83%	-$1.09M	﹤0.01%	438
2021 Q4	$1.41K	Sell	5,403 -32,085	-86%	-$8.33M	﹤0.01%	342
2021 Q3	$9.9K	Buy	37,488 +7,983	+27%	+$2.18M	0.02%	275
2021 Q2	$7.29K	Buy	29,505 +26,593	+913%	+$5.59M	0.02%	324
2021 Q1	$565	Buy	2,912 +326	+13%	+$65.4K	﹤0.01%	371
2020 Q4	$551	Sell	2,586 -771	-23%	-$154K	﹤0.01%	362
2020 Q3	$574K	Buy	3,357 +34	+1%	+$6.28K	0.01%	353
2020 Q2	$638K	Sell	3,323 -3,910	-54%	-$640K	0.01%	330
2020 Q1	$1.06M	Buy	+7,233	New	+$1.15M	0.01%	281

Other funds holding RMD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

M&G Investment Management's RMD Position: Q4 2023 in Review

M&G Investment Management sold out of ResMed (RMD) in Q4 2023, closing a stake of 40,766 shares — an estimated $6.03M sold.

M&G Investment Management first reported a position in RMD in Q1 2020 and held it in 10 quarters. The position peaked at $6.03M in Q3 2023. 687 funds tracked by Wall St. Rank hold RMD as of Q4 2023.

M&G Investment Management reported no remaining ResMed position as of Q4 2023 after selling out during the quarter.
M&G Investment Management sold 40,766 ResMed shares in Q4 2023, an estimated $6.03M.
M&G Investment Management first reported a position in ResMed in Q1 2020 and held it in 10 quarters.
M&G Investment Management's ResMed position peaked at $6.03M in Q3 2023.
687 funds tracked by Wall St. Rank held ResMed as of Q4 2023.

Based on M&G Investment Management's 13F filing for Q4 2023, filed 8 Feb 2024.